CMND ▼ -2.6% - Clearmind Medicine Inc.
$CMND - Clearmind Reaches Key Milestone: CMND-100 Phase IIa now Underway for Alcohol Use Disorder Trial, One-Third of Part C Enrolled
Clearmind Medicine shares declined 2.6% today despite announcing progress on its CMND-100 Phase IIa trial for alcohol use disorder treatment, with enrollment now at one-third capacity for Part C of the study. The pullback suggests investors may have interpreted the milestone as incrementally slower than expected or were taking profits following recent moves.
01-SEP-2026 07:37 AM ET
Share this post
More filings for $CMND
CMND - Clearmind Medicine Inc. - SEC Filing Update (16-NOV-2026) | ThinkSabio - Stocks SimplifiedNov 16, 2026CMND ▼ -3.8% - Clearmind Medicine Inc.Nov 16, 2026CMND ▼ -1.4% - Clearmind Medicine Inc.Oct 12, 2026CMND ▼ -0.9% - Clearmind Medicine Inc.Oct 8, 2026CMND ▼ -11.1% - Clearmind Medicine Inc.Oct 7, 2026CMND ▼ -11.1% - Clearmind Medicine Inc.Oct 7, 2026
View full $CMND filing history →💬 Comments
Loading comments…
Leave a comment
